Claritin Supply Sufficient For Spring, Schering Says; FDA Lists GMP Problems
Executive Summary
Schering-Plough will have a sufficient supply of Claritin for the spring allergy season, the company maintains.
You may also be interested in...
Schering Albuterol Recall Linked With 24 Fatalities, Public Citizen Asserts
Schering-Plough's testing of albuterol inhalers returned to the company shows that in every case where an injury is alleged to have occurred because of a faulty inhaler, the canister contained active ingredient, the company maintains.
Schering Albuterol Recall Linked With 24 Fatalities, Public Citizen Asserts
Schering-Plough's testing of albuterol inhalers returned to the company shows that in every case where an injury is alleged to have occurred because of a faulty inhaler, the canister contained active ingredient, the company maintains.
Nasonex Delivery Failures Are Among Observations In Schering FDA-483s
One theme of FDA's recent inspections of Schering-Plough's Manati, Puerto Rico manufacturing facility is the reliability of the nasal spray delivery system for Nasonex (mometasone).